CNBC October 11, 2024
Jessica Dickler

Key Points

– About 165 million Americans rely on employer-sponsored health insurance, and yet workers may still not get the coverage they want — particularly when it comes to drugs such as Wegovy and Ozempic.

– Currently, less than half of employers cover the expensive weight-loss medications.

– Even those that do cover them have guardrails in place that restrict access.

About 165 million Americans rely on employer-sponsored health insurance, and yet workers may still not get the coverage they want — particularly when it comes to drugs such as Novo Nordisk’s weight-loss drug Wegovy and diabetes drug Ozempic.

About 1 in 3 employees are looking for more resources to combat obesity, according to a recent report by consulting firm...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Employer, Healthcare System, Patient / Consumer, Pharma / Biotech, Pricing / Spending
The Future of Hospitals and Pharma Companies Will Depend on Strength of Healthcare Analytics Insights
Revolutionizing Pharma: The Power of AI and Chatbots in Clinical Trials and Beyond
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
The biotech news you missed this weekend
Lundbeck drops in on epilepsy drug with $2.6bn Longboard bid

Share This Article